End-of-life care issues are complex and difficult, and in the realm of public policy where a zero-sum game over ethical alternatives is the norm these issues can further divide an already polarized nation. Too often, partisans frame the national debate as if the only choice were between patients receiving drastic interventions (such as being hooked up to a machine that artificially extends life indefinitely) or allowing physicians to assist in the suicides of their patients. There is, however, a wide area between these two extreme options.
As Democrats hurry to finalize $739 billion in climate, health care and tax legislation that was revived last week to the surprise of most Washington insiders, business lobbyists and issue advocates are working to support, tweak or derail the bill entirely.
Democrats Face Tough Messaging War on Prescription Drug Bill bgov.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bgov.com Daily Mail and Mail on Sunday newspapers.
Latest Prescription Drug Price Negotiation Draft Takes Two Steps Back for Seniors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
OpenSecrets' new analysis of 2021 lobbying expenditure data shows that many of the same organizations are working across federal and state levels of government to impact public policy on similar issues